Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes.

Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N, Das P.

Trans R Soc Trop Med Hyg. 2011 Nov;105(11):661-6. doi: 10.1016/j.trstmh.2011.08.005. Epub 2011 Sep 25.

PMID:
21945327
2.

Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India.

Srivastava P, Gidwani K, Picado A, Van der Auwera G, Tiwary P, Ostyn B, Dujardin JC, Boelaert M, Sundar S.

Trop Med Int Health. 2013 May;18(5):548-54. doi: 10.1111/tmi.12085. Epub 2013 Mar 7.

3.

Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, Rijal S, Sundar S, Boelaert M.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1284. doi: 10.1371/journal.pntd.0001284. Epub 2011 Oct 4.

4.

Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India.

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R, Das P.

Am J Trop Med Hyg. 2010 Sep;83(3):502-6. doi: 10.4269/ajtmh.2010.09-0345.

5.

Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?

Das S, Matlashewski G, Bhunia GS, Kesari S, Das P.

Trans R Soc Trop Med Hyg. 2014 Nov;108(11):679-84. doi: 10.1093/trstmh/tru146. Epub 2014 Sep 9. Review.

PMID:
25205664
6.

Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.

Khalil EA, Zijlstra EE, Kager PA, El Hassan AM.

Trop Med Int Health. 2002 Jan;7(1):35-44.

7.

Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.

Singh RP, Picado A, Alam S, Hasker E, Singh SP, Ostyn B, Chappuis F, Sundar S, Boelaert M.

Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.

8.

Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.

Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, Chourasia A, Singh AK, Shankar R, Menten J, Wilson ME, Boelaert M, Sundar S.

PLoS Negl Trop Dis. 2013;7(2):e2053. doi: 10.1371/journal.pntd.0002053. Epub 2013 Feb 14. Erratum in: PLoS Negl Trop Dis. 2013 Apr;7(4). doi:10.1371/annotation/f096e293-9b24-46e6-bf1e-a18696611b4d. Wilson, Mary Elizabeth [corrected to Wilson, Mary Edyth].

9.

Relevance of direct agglutination test in seroepidemiological survey of Kala-azar in epidemic foci of Bihar.

Sharma MC, Bimal S, Ranjan A, Das VN, Gupta AK, Kumar N, Kar SK.

J Commun Dis. 2000 Jun;32(2):117-22.

PMID:
11198396
10.

Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India.

Gidwani K, Kumar R, Rai M, Sundar S.

Am J Trop Med Hyg. 2009 Mar;80(3):345-6.

11.

Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India.

Das P, Samuels S, Desjeux P, Mittal A, Topno R, Siddiqui NA, Sur D, Pandey A, Sarnoff R.

Trop Med Int Health. 2010 Jul;15 Suppl 2:4-11. doi: 10.1111/j.1365-3156.2010.02517.x. Epub 2010 May 6.

12.

Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.

Burza S, Sinha PK, Mahajan R, Sanz MG, Lima MA, Mitra G, Verma N, Das P.

PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014.

13.

Leishmaniasis in Sudan. Visceral leishmaniasis.

Zijlstra EE, el-Hassan AM.

Trans R Soc Trop Med Hyg. 2001 Apr;95 Suppl 1:S27-58.

PMID:
11370250
14.

Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study.

Bimal S, Das VN, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Sen A, Bhattacharya SK, Das P.

Ann Trop Med Parasitol. 2005 Dec;99(8):743-9.

PMID:
16297287
15.
16.

Visceral leishmaniasis in Nepal during 1980-2006.

Joshi DD, Sharma M, Bhandari S.

J Commun Dis. 2006 Mar;38(2):139-48.

PMID:
17370676
17.

Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.

Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M.

Trop Med Int Health. 2006 Dec;11(12):1792-9.

18.

Low castes have poor access to visceral leishmaniasis treatment in Bihar, India.

Pascual Martínez F, Picado A, Roddy P, Palma P.

Trop Med Int Health. 2012 May;17(5):666-73. doi: 10.1111/j.1365-3156.2012.02960.x. Epub 2012 Mar 5.

19.

Leishmania donovani in blood smears of asymptomatic persons.

Sharma MC, Gupta AK, Das VN, Verma N, Kumar N, Saran R, Kar SK.

Acta Trop. 2000 Sep 18;76(2):195-6.

PMID:
10936579
20.

Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.

Picado A, Ostyn B, Singh SP, Uranw S, Hasker E, Rijal S, Sundar S, Boelaert M, Chappuis F.

PLoS One. 2014 Jan 31;9(1):e87641. doi: 10.1371/journal.pone.0087641. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk